ERIN CUBIT

IHA advocated to our Members of Congress as well as to the Centers for Medicare and Medicaid Services (CMS) on issues related to: Medicaid State-Directed Payments, site-neutral policies, the 340B Drug Payment Program, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comments to the Centers for Medicare and Medicaid Services on the Calendar Year 2026 Outpatient Prospective Payment System proposed rule and the Calendar Year 2026 Home Health Prospective Payment System proposed rule as well as to the Department of Health and Human Services' 340B Rebate Model Pilot Program.

IHA advocated to our Members of Congress as well as to the Centers for Medicare and Medicaid Services (CMS) on issues related to: Medicaid State-Directed Payments, site-neutral policies, the 340B Drug Payment Program, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comments to the Centers for Medicare and Medicaid Services on the Calendar Year 2026 Outpatient Prospective Payment System proposed rule and the Calendar Year 2026 Home Health Prospective Payment System proposed rule as well as to the Department of Health and Human Services' 340B Rebate Model Pilot Program.

IHA advocated to our Members of Congress as well as to the Centers for Medicare and Medicaid Services (CMS) on issues related to: Medicaid, site-neutral policies, the 340B Drug Payment Program, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comments to the Centers for Medicare and Medicaid Services on the Fiscal Year 2026 Inpatient Prospective Payment System proposed rule and to the Office of Management and Budget's request for information on deregulation.

IHA advocated to our Members of Congress as well as to the Centers for Medicare and Medicaid Services (CMS) on issues related to: Medicaid, site-neutral policies, the 340B Drug Payment Program, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comments to the Centers for Medicare and Medicaid Services on the Fiscal Year 2026 Inpatient Prospective Payment System proposed rule and to the Office of Management and Budget's request for information on deregulation.

IHA advocated to our Members of Congress as well as to the Centers for Medicare and Medicaid Services (CMS) on issues related to: Medicaid, site-neutral policies, the 340B Drug Payment Program, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comments to CMS on the Calendar Year 2026 Medicare Advantage proposed rule.

IHA advocated to our Members of Congress as well as to the Centers for Medicare and Medicaid Services (CMS) on issues related to: Medicaid, site-neutral policies, the 340B Drug Payment Program, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comments to CMS on the Calendar Year 2026 Medicare Advantage proposed rule.

IHA advocated to our Members of Congress as well as to CMS on issues related to: Site-neutral policies, 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to the HHS National Coordinator of Health Information Technology on a proposed rule pertaining to health data, technology and interoperability.

IHA advocated to our Members of Congress as well as to CMS on issues related to: Site-neutral policies, 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to the HHS National Coordinator of Health Information Technology on a proposed rule pertaining to health data, technology and interoperability.

IHA advocated to our Members of Congress as well as to CMS on issues related to: Site-neutral policies, 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to CMS on their proposed rule on the Calendar Year 2025 Hospital Outpatient Prospective Payment System, Calendar Year 2025 Home Health Prospective Payment System, and the Calendar Year 2025 Physician Fee Schedule. Additionally, IHA has submitted comment to the Department of Homeland Security and the Cybersecurity and Infrastructure Security Agency on a proposed rule pertaining to cyber incident reporting, as well as the HHS National Coordinator of Health Information Technology on a proposed rule pertaining to health data, technology and interoperability.

IHA advocated to our Members of Congress as well as to CMS on issues related to: Site-neutral policies, 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to CMS on their proposed rule on the Fiscal Year 2025 Inpatient Prospective Payment System and comment on the request for information from HHS, DOJ and the FTC on consolidation in health care.

IHA advocated to our Members of Congress as well as to CMS on issues related to: Site-neutral policies, 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to CMS on their proposed rule on the Fiscal Year 2025 Inpatient Prospective Payment System and comment on the request for information from HHS, DOJ and the FTC on consolidation in health care.

IHA advocated to our Members of Congress as well as to CMS on issues related to: Site-neutral policies, 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to CMS on their proposed rule on the Fiscal Year 2025 Inpatient Prospective Payment System and comment on the request for information from HHS, DOJ and the FTC on consolidation in health care.

IHA advocated to our Members of Congress as well as to CMS on issues related to: Site-neutral policies, 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to CMS on their proposed rule on the Calendar Year 2025 Medicare Advantage and their proposed rule on information blocking disincentives.

IHA advocated to our Members of Congress as well as to CMS on issues related to: Site-neutral policies, 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to CMS on their proposed rule on the Calendar Year 2025 Medicare Advantage and their proposed rule on information blocking disincentives.

IHA advocated to our Members of Congress as well as to CMS on issues related to: Site-neutral policies, 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to CMS on their proposed rule on nurse staffing ratios.

IHA advocated to our Members of Congress as well as to CMS on issues related to: Site-neutral policies, 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to CMS on their proposed rules on the Outpatient Prospective Payment System and the proposed rule on HHS's remedy on 340B payments. IHA also submitted comments to the Federal Trade Commission and the Department of Justice on their proposed rule on draft merger guidelines, and to the Federal Trade Commission on the Hart, Scott, Rodeno Coverage Exemption and Transmittal rules.

IHA advocated to our Members of Congress as well as to CMS on issues related to: Site-neutral policies, 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to CMS on their proposed rules on the Inpatient Prospective Payment System proposed rule and the proposed rule on Medicaid Managed Care. IHA also submitted comments to the Federal Trade Commission on their proposed rule banning non-compete agreements.

IHA advocated to our Members of Congress as well as to CMS on issues related to: 340B, hospital finances, workforce concerns, regulatory relief and other similar topics related to hospital sustainability and operations. IHA also submitted comment to CMS on their proposed rules on the 340B administrative dispute resolution process, prior authorization standardization process and the annual Medicare Advantage payment rule.

Held regular conference calls (approximately monthly) and/or emailed with Iowa's Congressional Delegation staff (House and Senate) to discuss issues related to Rural Emergency Hospitals (REH) and other general topics that include the 340B Drug Pricing Program, traveling nurse staffing, Medicare sequestration, workforce and Provider Relief Funds. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues and issues related to the COVID-19 pandemic.

Held regular conference calls (approximately monthly) and/or emailed with Iowa's Congressional Delegation staff (House and Senate) to discuss issues related to Rural Emergency Hospitals (REH) and other general topics that include the 340B Drug Pricing Program, traveling nurse staffing, Medicare sequestration, workforce and Provider Relief Funds. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic. This includes submitting written comments to the CY2023 Outpatient Prospective Payment System proposed rule for PPS hospitals and the proposed rule on the REH Conditions of Participation.

Held regular conference calls (approximately monthly) and/or emailed with Iowa's Congressional Delegation staff (House and Senate) to discuss issues related to the COVID-19 pandemic, Rural Emergency Hospitals and other general topics that include the 340B Drug Pricing Program, traveling nurse staffing, Medicare sequestration, workforce and Provider Relief Funds. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic. This includes submitting written comments to the FY2023 Inpatient Prospective Payment System proposed rule for PPS hospitals.

Held regular conference calls (approximately monthly) and/or emailed with Iowa's Congressional Delegation staff (House and Senate) to discuss issues related to the COVID-19 pandemic, Rural Emergency Hospitals and other general topics that include the 340B Drug Pricing Program, traveling nurse staffing and Provider Relief Funds. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic.

Held regular conference calls (approximately monthly) and/or emailed with Iowa's Congressional Delegation staff (House and Senate) to discuss issues related to the COVID-19 pandemic, Rural Emergency Hospitals and other general topics that include the 340B Drug Pricing Program, traveling nurse staffing and Provider Relief Funds. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic as well as submitted written comment to CMS's CY2023 Outpatient Prospective Payment System proposed rule and regulations around Surprise Medical Billing.

Scheduled and held regular conference calls (approximately monthly) with Iowa's Congressional Delegation staff (House and Senate) to discuss issues related to the COVID-19 pandemic, rural hospital payment reform and other general topics that include the 340B Drug Pricing Program and Provider Relief Funds. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic as well as submitted written comment to CMS's CY2022 Outpatient Prospective Payment System proposed rule and OSHA's Emergency Temporary Standards Related to COVID-19.

Scheduled and held regular conference calls (approximately monthly) with Iowa's Congressional Delegation staff (House and Senate) to discuss issues related to the COVID-19 pandemic, rural hospital payment reform and other general topics that include the 340B Drug Pricing Program and Provider Relief Funds. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic as well as submitted written comment to CMS's FY2022 Inpatient Prospective Payment System proposed rule.

Scheduled and held regular conference calls (approximately monthly) with Iowa's Congressional Delegation staff (House and Senate) to discuss issues related to the COVID-19 pandemic, rural hospital payment reform and other general topics that include the 340B Drug Pricing Program and Medicare Accelerated Payments. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic.

Scheduled and held regular conference calls (approximately two a month) with Iowa's Congressional Delegation and staffers (House and Senate) to discuss issues related to the COVID-19 pandemic, rural hospital payment reform and other general hospital topics that include the 340B Drug Program and Medicare Accelerated Payments. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic. IHA also submitted comments on proposed rules pertaining to CY 2021 OPPS, CY 2021 Physician Fee Schedule and hospital COVID-19 data reporting.

Scheduled and held regular conference calls (approximately two a month) with Iowa's Congressional Delegation and staffers (House and Senate) to discuss issues related to the COVID-19 pandemic, rural hospital payment reform and other general hospital topics that include the 340B Drug Program and Medicare Accelerated Payments. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic. IHA also submitted comments on proposed rules pertaining to CY 2021 OPPS, CY 2021 Physician Fee Schedule and hospital COVID-19 data reporting.

Scheduled and held regular conference calls (approximately two a month) with Iowa's Congressional Delegation and staffers (House and Senate) to discuss issues related to the COVID-19 pandemic, rural hospital payment reform and other general hospital topics that include the 340B Drug Program and Medicare Accelerated Payments. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic. IHA also submitted comments on proposed rules pertaining to FY 2021 IPPS, CY 2021 OPPS and CY 2021 physician fee schedule.

Scheduled and held regular conference calls (approximately two a month) with Iowa's Congressional Delegation and staffers (House and Senate) to discuss issues related to the COVID-19 pandemic, rural hospital payment reform and other general hospital topics. Finally, IHA also stayed in contact with the Centers for Medicare & Medicaid Services on hospital issues related to the COVID-19 pandemic.

Scheduled and held in-person visits with Iowa's Congressional Delegation staffers (House and Senate) to discuss rural hospital payment reform and other general hospital topics. Phone calls were had with Congressional Staffers and Iowa's Congressional Delegation on controlling prescription drug pricing, the 340B prescriptive drug discount program, rejecting 'site-neutral' payment cuts, IHA's Rural Health Care Innovation Taskforce rural hospital report and how Congress can help hospitals during the COVID-19 epidemic. Finally, IHA submitted comments to CMS on the Coverage Transparency and the Medicaid Fiscal Accountability proposed rule.

Scheduled and held in-person visits with Iowa's Congressional Delegation staffers (House and Senate) to discuss rural hospital payment reform, controlling prescription drug pricing, the 340B prescriptive drug discount program, rejecting 'site-neutral' payment cuts and IHA's Rural Health Care Innovation Taskforce rural hospital report. Additionally, phone calls and emails were made to members of Iowa's Congressional Delegation on rural hospital payment reform, Medicaid DSH, and surprise billing. Finally, IHA submitted comments to CMS on the Home Health Prospective Payment System and the Stark and Anti-kickback Statute proposed rules.

Scheduled and held in-person visits with Iowa's Congressional Delegation staffers (House and Senate) to discuss rural hospital payment reform, controlling prescription drug pricing, the 340B prescriptive drug discount program, rejecting 'site-neutral' payment cuts and IHA's Rural Health Care Innovation Taskforce rural hospital report. Additionally, phone calls and emails were made to members of Iowa's Congressional Delegation on rural hospital payment reform, Medicaid DSH, and surprise billing. Finally, IHA submitted comments to CMS on the Outpatient Prospective Payment System proposed rule..

Scheduled and held in-person visits with Iowa's Congressional Delegation staffers (House and Senate) to discuss rural hospital payment reform, controlling prescription drug pricing, the 340B prescriptive drug discount program, rejecting 'site-neutral' payment cuts and IHA's Rural Health Care Innovation Taskforce rural hospital report. Additionally, phone calls and emails were made to members of Iowa's Congressional Delegation on rural hospital payment reform, Medicaid DSH, an 1135 Waiver request, the changes on hospital wage index calculations in the Inpatient Prospective Payment System proposed rule and surprise billing. Finally, IHA submitted comments to CMS on the Inpatient Prospective Payment System proposed rule, the draft guidance on ligature risk and the draft guidance on co-location.

Policies impacting hospitals Medicare and Medicaid Rural health

Policies impacting hospitals Medicare and Medicaid Rural health